|
|
|
|
| LEADER |
03430nmm a2200325 u 4500 |
| 001 |
EB000735734 |
| 003 |
EBX01000000000000000587166 |
| 005 |
00000000000000.0 |
| 007 |
cr||||||||||||||||||||| |
| 008 |
140303 ||| eng |
| 020 |
|
|
|a 9781493902682
|
| 100 |
1 |
|
|a Jugdutt, Bodh I.
|e [editor]
|
| 245 |
0 |
0 |
|a Aging and Heart Failure
|h Elektronische Ressource
|b Mechanisms and Management
|c edited by Bodh I. Jugdutt
|
| 250 |
|
|
|a 1st ed. 2014
|
| 260 |
|
|
|a New York, NY
|b Springer New York
|c 2014, 2014
|
| 300 |
|
|
|a XXII, 475 p. 84 illus., 50 illus. in color
|b online resource
|
| 505 |
0 |
|
|a Effect of right ventricular and pulmonary artery remodeling -- Biomarkers of cardiovascular aging -- Changes in the heart that accompany advancing age: Humans to molecules -- Aging-related changes in cell death and cell survival pathways and implications for heart failure therapy -- Aging-related changes in telomeres and telomerases and implications for heart failure therapy --
|
| 505 |
0 |
|
|a pathophysiological perspectives and clinical implications -- Aging-related changes in extracellular matrix: implications for ventricular remodeling following myocardial infarction -- Calcium handling defects and changes in cardiac function in the aging heart -- Integrins: Implications for aging in heart failure therapy -- Adipokines as novel biomarkers in aging and heart failure -- Aging-related changes in cellular and molecular mechanisms of post-infarction remodeling. Implications for heart failure therapy -- Aging-related changes in mitochondrial function and implication for heart failure therapy -- Regulation of SERCA via oxidative modifications: Implications for the pathophysiology of diastolic dysfunction in the aging heart -- SMP-30 and aging-related cardiac remodeling and heart failure
|
| 505 |
0 |
|
|a an update on clinical trials and opportunities for therapy --
|
| 653 |
|
|
|a Geriatrics
|
| 653 |
|
|
|a Internal medicine
|
| 653 |
|
|
|a Cardiology
|
| 653 |
|
|
|a Geriatrics/Gerontology
|
| 653 |
|
|
|a Cardiology
|
| 653 |
|
|
|a Internal Medicine
|
| 041 |
0 |
7 |
|a eng
|2 ISO 639-2
|
| 989 |
|
|
|b Springer
|a Springer eBooks 2005-
|
| 856 |
4 |
0 |
|u https://doi.org/10.1007/978-1-4939-0268-2?nosfx=y
|x Verlag
|3 Volltext
|
| 082 |
0 |
|
|a 616.12
|
| 520 |
|
|
|a This book synthesizes the major research advances in molecular, biochemical, and translational aspects of aging and heart failure over the last four decades and addresses future directions in management and drug discovery. It presents clinical issues and molecular mechanisms related to heart failure, including the changing demographics in the aging population with heart failure; hypertension and prevention of diastolic heart failure in the aging population; polypharmacy and adverse drug reactions in the aging population with heart failure; changes in the heart that accompany advancing age from humans to molecules; aging-associated alterations in myocardial inflammation and fibrosis; and aging-related changes in mitochondrial function and implications for heart failure therapy. The book succinctly summarizes the large volume of data on these key topics and highlights novel pathways that need to be explored. Featuring contributions from leading clinician-scientists, Aging and Heart Failure: Mechanisms and Management is an authoritative resource on the major clinical issues in heart failure therapy in the elderly for cardiologists, gerontologists, and internists
|